AIDS
- CHERKOS AS, Cranmer LM, Njuguna I, LaCourse SM, et al
Effect of TB-HIV co-treatment on clinical and growth outcomes among hospitalized
children newly initiating antiretroviral therapy.
AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003797.
Antimicrob Agents Chemother
- LI S-Y, Tyagi S, Soni H, Betoudji F, et al
Bactericidal and sterilizing activity of novel regimens combining bedaquiline or
TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis.
Antimicrob Agents Chemother. 2024 Feb 20:e0156223. doi: 10.1128/aac.01562.
Eur J Clin Microbiol Infect Dis
- CAO X, Guo T, Xin H, Du J, et al
Cost-effectiveness of latent tuberculosis infection testing and treatment with
6-week regimen among key population in rural communities in China: a decision
analysis study.
Eur J Clin Microbiol Infect Dis. 2024 Feb 22. doi: 10.1007/s10096-024-04777.
J Infect Dis
- OH IS, Kim JH, Huh K, Jang SH, et al
Impact of National Public-Private Mix and Medical Expense Support Program for
Control Tuberculosis in South Korea: An Interrupted Time Series Analysis.
J Infect Dis. 2024 Feb 14:jiae059. doi: 10.1093.
PLoS Med
- SEMITALA FC, Kadota JL, Musinguzi A, Welishe F, et al
Comparison of 3 optimized delivery strategies for completion of
isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with
HIV in Uganda: A single-center randomized trial.
PLoS Med. 2024;21:e1004356.
PLoS One
- CHAVAN VV, Dalal A, Nagaraja S, Thekkur P, et al
Correction: Ambulatory management of pre- and extensively drug resistant
tuberculosis patients with imipenem delivered through port-a-cath: A mixed
methods study on treatment outcomes and challenges.
PLoS One. 2024;19:e0299477.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016